Day: March 8, 2023

Company Reports Second-Highest Quarterly Revenue in Company History LINDON, Utah, March 08, 2023 (GLOBE NEWSWIRE) — Profire Energy, Inc. (NASDAQ: PFIE), a technology company (the “Company”) that provides solutions which enhance the efficiency, safety, and reliability of industrial combustion appliances, today reported financial results for its fourth quarter and full fiscal year ending December 31, 2022. A conference call will be held on Thursday, March 9, 2023 at 8:30 a.m. ET to discuss the results. Fourth Quarter SummaryRevenue of $14.0 million, a 69% increase from prior year quarter Gross profit of $6.6 million, a 91% increase compared to the same quarter of 2021 Gross margin of 47.0%, a 540 basis point increase from prior year quarter Net Income of $1.8 million, or $0.04 per diluted share Generated EBITDA of $2.6...

Full-Year Net Revenue of $10 Million and Fourth Quarter Net Revenue of $2.6 Million SOUTH ORANGE, NJ, March 08, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31, 2022. Financial Highlights Fourth Quarter Ended December 31, 2022 – ConsolidatedNet revenue from continuing operations was $2.6 million, compared to $2.7 million in the fourth quarter of 2021, down 6% Net loss from continuing operations was ($0.7 million), approximately equal to the same period in 2021 Adjusted EBITDA from continuing operations was ($0.5 million), compared to ($0.1 million) in the fourth quarter of 2021Year-End 2022 – Consolidated...

Announced Expansion of Briquilimab (formerly known as JSP191) Development Strategy to Include Chronic Spontaneous Urticaria Presentation of Key Briquilimab Clinical Data, Including Initial Results in Stem Cell Transplant for Sickle Cell Disease and One Year Follow-Up for Acute Myeloid Leukemia Transplant Patients Raised $101.4 Million Net Proceeds in January 2023REDWOOD CITY, Calif., March 08, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndromes (MDS) as well as novel stem cell transplant conditioning regimes, today announced results for the fiscal year ended December 31, 2022, and provided...

Fourth Quarter Revenue Increased 16% to $13.1 Million Producing $4.4 Million of Cash Flow from Operations Full Year 2022 Revenue Increased 21% to $53.3 Million Generating Net Income of $0.6 Million BOCA RATON, Fla., March 08, 2023 (GLOBE NEWSWIRE) — Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced financial results for the quarter and full year ended December 31, 2022. “2022 was another record year for red violet. The target markets for our solutions continue to exhibit solid fundamentals and increasing opportunity, notwithstanding the uncertain economic environment,” stated Derek Dubner, red violet’s CEO. “We remain intently focused on utilizing our healthy cash flow generation to strategically invest in our deep product roadmap and to further expand the capabilities and...

Fourth Quarter 2022 Company-Owned Comparable Restaurant Sales Increase 10.2%; Significant Expansion of Operating Margin and Restaurant Contribution Margin Compared to Fourth Quarter 2021 BROOMFIELD, Colo., March 08, 2023 (GLOBE NEWSWIRE) — Noodles & Company (Nasdaq: NDLS) today announced financial results for the fourth quarter and fiscal year ended January 3, 2023, and provided a 2023 business outlook. Key highlights for the fourth quarter of 2022 compared to the same quarter of 2021 include:Total revenue increased 18.9% to $136.5 million from $114.8 million. Comparable restaurant sales increased 10.2% for company-owned restaurants, 1.3% for franchise restaurants and 8.7% system-wide. Net income was $1.0 million, or $0.02 per diluted share, compared to a net loss of $4.7 million, or $0.10 loss per diluted share. Operating...

WOODCLIFF LAKE, N.J., March 08, 2023 (GLOBE NEWSWIRE) — Hudson Technologies, Inc. (NASDAQ: HDSN) announced results for the fourth quarter and year ended December 31, 2022. For the quarter ended December 31, 2022, Hudson reported revenues of $47.4 million, an increase of 26% compared to revenues of $37.8 million in the comparable 2021 period. Fourth quarter revenue growth was driven by increased selling prices for certain refrigerants during the period as well as increased sales volume in the quarter as compared to the fourth quarter of 2021. Gross margin in the fourth quarter of 2022 was 32%, compared to 45% in the fourth quarter of 2021. Hudson reported operating income of $7.1 million in the fourth quarter of 2022, compared to operating income of $9.3 million in the prior year period. The Company recorded net income of $5.1 million...

Record full year 2022 net sales of $8.6 million increased 58% over $5.5 million for full year 2021 Company to host conference call and webcast today, March 8, 2023 at 4:30pm EST ROCKAWAY, N.J., March 08, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR) (the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced fourth quarter and full year 2022 financial results and provided an operational update. Fourth Quarter 2022 and Recent HighlightsReported record full year 2022 net sales of $8.6 million, representing an increase of 58% over $5.5 million for full year 2021 Fourth quarter net sales of $2.6 million, an increase of 72% over $1.5 million for the fourth quarter of 2021 Launched two new brands: TAC-STIM™ under the Air Force BOOST program and Truvaga™ wellness product...

FY 2022 Net Sales and Adjusted EBITDA1 Exceed Previously Provided GuidanceFY 2023 Guidance Demonstrates Continued Strong Momentum on Top and Bottom Line LOUISVILLE, Colo., March 08, 2023 (GLOBE NEWSWIRE) — Sovos Brands, Inc. (“Sovos Brands” or the “Company”) (Nasdaq: SOVO), one of the fastest-growing food companies of scale in the United States, today reported financial results for its fourth quarter and fiscal year ended December 31, 2022. Fourth Quarter Highlights:Net sales were $262.1 million, a 38.5% increase over the prior year period, or 28.4% organic growth, driven by 16.0% volume and 12.4% pricing growth. The extra week in the Fourth Quarter 2022 compared to the prior year period contributed $19.1 million or 10.1% to growth2 Rao’s net sales for the quarter were $187.7 million, up 56.0% year-over-year or 44.6% on an organic...

SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other life science companies, today announced financial results for the fourth quarter and year ended December 31, 2022. The Company will host a conference call and webcast today at 4:30 PM Eastern Time / 1:30 PM Pacific Time. “The significant progress we achieved in the fourth quarter sets up 2023 to be a potentially transformational year for TRACON,” said Charles Theuer, M.D., Ph.D., President and CEO of TRACON. “In December we announced interim efficacy results from the ongoing ENVASARC pivotal trial demonstrating that envafolimab achieved a...